It might be a good idea for community cancer centers to start screening for hepatitis B and C, because an alarmingly high rate of patients with cancer has undiagnosed acute and chronic hepatitis.
Investigators from SWOG Cancer Research Network, an international cancer clinical trials group funded by the National Cancer Institute, found that a substantial portion of newly diagnosed cancer patients with HBV or HCV were unaware of their viral infection. Many had no identifiable risk factors